Cycle 2
SIDE EFFECT
Starting in June of 2021, the message template feature was made available to half of platform providers, selected at random. To assess the effectiveness of message templates, we examined the rates of treatment continuation among the 754 patients who reported a side effect and received counseling during that June. We compared the continuation rates between patients whose interactions with providers involved the use of message templates (All analyses for both cycles were conducted in R version 4.1.